Viking Global Investors, 10% Owner: BridgeBio Pharma BBIO Sell · Filed 23/07/19

Trade details

Type: Insider sale
Amount: $52,500,000
Shares · price: 1,500,000 sh · $35.00 a share
Held after: 25,120,991 sh
Stock: BridgeBio Pharma BBIO
Person: Viking Global Investors10% Owner
Trade date: 23/07/18
Filed: 23/07/19
Days to filing: 1 days

Sold 5.6% of holdings

Share of holding sold: 5.6%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 23/06/18~23/08/17

Viking Global Investors's recent trades

Viking Global Investors10% Owner
SellInhibrx Biosciences
Sell
Inhibrx Biosciences
INBX
$10M
308,643 sh
$10M
Filed 25/10/09
Traded 25/10/07
Viking Global Investors10% Owner
SellInhibrx Biosciences
Sell
Inhibrx Biosciences
INBX
$807.6K
25,042 sh
$807.6K
Filed 25/10/09
Traded 25/10/07
Viking Global Investors10% Owner
SellInhibrx Biosciences
Sell
Inhibrx Biosciences
INBX
$526.2K
16,315 sh
$526.2K
Filed 25/10/09
Traded 25/10/07
Viking Global Investors10% Owner
SellBridgeBio Pharma
Sell
BridgeBio Pharma
BBIO
$154M
3,500,000 sh
$154M
Filed 25/07/01
Traded 25/06/27
Viking Global Investors10% Stockholder
Planned saleBridgeBio Pharma
Planned sale
BridgeBio Pharma
BBIO
$107M
3,065,616 sh
$107M
Filed 25/01/31
Traded 25/01/31